Drugs in the making.com
Dr.Shruti Bhat, an Expert in Pharmaceutical industry, brings to you some highlights from current pharma and clinical research news, views and data.
Starting Metformin Within Three Months Of Diabetes Diagnosis May Increase Drug's Efficacy. According to a study published in the March issue of the journal Diabetes Care, "starting patients with metformin within 3 months of their diabetes diagnosis increases the drug's efficacy...
Somaxon Receives FDA Approval For Insomnia Drug. Development-stage biotech company Somaxon Pharmaceuticals Inc. said Thursday the Food and Drug Administration approved its delayed insomnia drug Silenor [doxepin] ...
Adding Cilostazol To Dual Antiplatelet Therapy May Not Improve Outcomes In DES Patients. A study presented at the American College of Cardiology meeting. reported that "adding cilostazol -- an antiplatelet approved in the US for treatment of intermittent claudication -- to standard dual antiplatelet therapy did not improve clinical outcomes in patients receiving drug-eluting stents ...
Gender-Based Drug Research Has Yet To Lead To Tailored Treatments. Time magazine that while "an estimated 12 million American women are routinely prescribed statins...there is little evidence that they prevent heart disease in women ...
Drug Combination Meets Key Milestone In Cancer Trial. According to Abraxis BioScience, Nanoparticle albumin-bound paclitaxel (Abraxane) "met a key milestone in a non-small cell lung cancer clinical trial ...
Minocycline May Help Halt HIV Progression In T Cells. According to a study released online in advance of publication in the April 15 print issue of the Journal of Infectious Diseases, minocycline (Minocin), "a cheap acne drug that's been used for decades, appears to target infected immune-system cells in which HIV lies dormant before ...
Twice Weekly Tacrolimus Ointment May Be Safe, Effective For Children With Atopic Dermatitis. According to research presented at the American Academy of Dermatology meeting, "tacrolimus 0.03% ointment applied twice weekly is effective and safe for children with moderate to ...
New Form Of Inhaled Insulin May Be Less Risky Than Exubera. According to research presented at a chemical society meeting, Afrezza (insulin human [rDNA origin]), "a new form of inhaled insulin, appears to help people with diabetes who must use insulin, with fewer potential risks than" Exubera (insulin inhaled ...
Disclaimer- The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
Full article at http://www.pharm-education.com/2010/03/starting-metformin-within-three-months.html
Expert at leading Pharmaceutical R&D.
Translates innovative concepts to PROFITS.
Do you have questions for the author?
Dr. Shruti U. Bhat
Pharmaceutical Manufacturing, Continuous Improvement and Business Transformation Consultant
New Release !
The information posted here, not limited to blogs, website, podcasts, videos, eBooks, whitepapers and other 'free' resources including downloaded items are Copyright protected, 'for review' purpose only. Not to be copied, distributed or used without prior written authorization by Dr. Shruti U. Bhat. Any instance(s) found to the contrary would be construed as copyright violation, illegal, plagiarism and/or could be subject to legal proceedings.
For additional details, refer our Terms & Conditions for site usage.
Kaizen book at # 4 on Amazon Best Sellers List!